Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology Department, Hospital | 2 | 2020 | 53 | 1.350 |
Why?
|
| Foreign Bodies | 2 | 2021 | 160 | 1.330 |
Why?
|
| Intestinal Volvulus | 2 | 2021 | 36 | 0.900 |
Why?
|
| Digestive System Abnormalities | 2 | 2021 | 41 | 0.900 |
Why?
|
| Nuclear Medicine | 2 | 2021 | 28 | 0.880 |
Why?
|
| Ileal Diseases | 2 | 2022 | 27 | 0.840 |
Why?
|
| Multimodal Imaging | 5 | 2020 | 550 | 0.780 |
Why?
|
| Intussusception | 1 | 2022 | 51 | 0.760 |
Why?
|
| Teleradiology | 1 | 2020 | 13 | 0.710 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 13 | 0.710 |
Why?
|
| Hospitals, Community | 1 | 2020 | 76 | 0.680 |
Why?
|
| Child Health Services | 1 | 2020 | 89 | 0.660 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 119 | 0.650 |
Why?
|
| KATP Channels | 1 | 2018 | 12 | 0.630 |
Why?
|
| Glucagon | 2 | 2018 | 197 | 0.630 |
Why?
|
| Pandemics | 5 | 2022 | 1614 | 0.620 |
Why?
|
| Potassium Channel Blockers | 1 | 2018 | 114 | 0.610 |
Why?
|
| Somatostatin | 1 | 2018 | 121 | 0.610 |
Why?
|
| Hospitals, Pediatric | 4 | 2022 | 796 | 0.570 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2022 | 1260 | 0.500 |
Why?
|
| Betacoronavirus | 1 | 2020 | 516 | 0.500 |
Why?
|
| Pancreas | 2 | 2018 | 739 | 0.490 |
Why?
|
| Radiopharmaceuticals | 9 | 2022 | 1341 | 0.470 |
Why?
|
| Ultrasonography | 5 | 2024 | 1929 | 0.460 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2023 | 7786 | 0.450 |
Why?
|
| Glucose | 2 | 2018 | 1209 | 0.420 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 626 | 0.420 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 703 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 1303 | 0.380 |
Why?
|
| Intestinal Obstruction | 2 | 2024 | 224 | 0.380 |
Why?
|
| Child | 23 | 2024 | 30596 | 0.380 |
Why?
|
| Pediatrics | 1 | 2020 | 1189 | 0.360 |
Why?
|
| Organometallic Compounds | 2 | 2021 | 208 | 0.330 |
Why?
|
| Receptors, Drug | 4 | 2002 | 61 | 0.330 |
Why?
|
| Workflow | 2 | 2021 | 278 | 0.330 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 4 | 2002 | 53 | 0.330 |
Why?
|
| Epilepsy | 1 | 2017 | 928 | 0.330 |
Why?
|
| Positron Emission Tomography Computed Tomography | 3 | 2021 | 881 | 0.310 |
Why?
|
| Potassium Channels | 4 | 2002 | 190 | 0.300 |
Why?
|
| Esophagus | 2 | 2021 | 562 | 0.300 |
Why?
|
| Infant | 8 | 2024 | 14045 | 0.300 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2002 | 317 | 0.290 |
Why?
|
| Positron-Emission Tomography | 6 | 2022 | 2198 | 0.280 |
Why?
|
| Islets of Langerhans | 3 | 2018 | 235 | 0.230 |
Why?
|
| Societies, Medical | 2 | 2021 | 1320 | 0.230 |
Why?
|
| Neuroendocrine Tumors | 2 | 2021 | 656 | 0.230 |
Why?
|
| Neuroblastoma | 2 | 2020 | 706 | 0.220 |
Why?
|
| Appendicitis | 2 | 2024 | 177 | 0.220 |
Why?
|
| Artificial Intelligence | 3 | 2023 | 429 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2024 | 17095 | 0.220 |
Why?
|
| Humans | 35 | 2024 | 271093 | 0.220 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 60 | 0.210 |
Why?
|
| Rectal Prolapse | 1 | 2021 | 7 | 0.200 |
Why?
|
| Enema | 1 | 2022 | 49 | 0.200 |
Why?
|
| Arylsulfotransferase | 1 | 2021 | 20 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2021 | 7900 | 0.200 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 125 | 0.190 |
Why?
|
| Myofibroma | 1 | 2021 | 12 | 0.190 |
Why?
|
| Insulin | 3 | 2002 | 1426 | 0.190 |
Why?
|
| Neuroimaging | 2 | 2021 | 402 | 0.180 |
Why?
|
| Organizational Objectives | 1 | 2020 | 66 | 0.180 |
Why?
|
| Quarantine | 1 | 2020 | 23 | 0.180 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2021 | 227 | 0.170 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 89 | 0.170 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 63 | 0.170 |
Why?
|
| Bronchi | 1 | 2021 | 325 | 0.170 |
Why?
|
| Colectomy | 1 | 2021 | 292 | 0.170 |
Why?
|
| Radiography | 2 | 2021 | 1993 | 0.170 |
Why?
|
| Octreotide | 1 | 2020 | 132 | 0.170 |
Why?
|
| Workplace | 1 | 2020 | 93 | 0.170 |
Why?
|
| Adolescent | 11 | 2023 | 32784 | 0.160 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 205 | 0.160 |
Why?
|
| Crohn Disease | 1 | 2021 | 331 | 0.150 |
Why?
|
| Retrospective Studies | 7 | 2023 | 39951 | 0.150 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2019 | 128 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2021 | 411 | 0.140 |
Why?
|
| Histiocytosis | 1 | 2017 | 55 | 0.140 |
Why?
|
| Contrast Media | 2 | 2021 | 1500 | 0.140 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 560 | 0.140 |
Why?
|
| Radiology | 1 | 2022 | 426 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 1115 | 0.130 |
Why?
|
| Whole Body Imaging | 1 | 2015 | 120 | 0.120 |
Why?
|
| Mice, Knockout | 4 | 2018 | 5692 | 0.110 |
Why?
|
| Gastric Emptying | 1 | 2014 | 99 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 831 | 0.110 |
Why?
|
| Gastroparesis | 1 | 2014 | 80 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 5938 | 0.110 |
Why?
|
| Nausea | 1 | 2014 | 539 | 0.100 |
Why?
|
| Models, Biological | 1 | 2000 | 3189 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2014 | 378 | 0.090 |
Why?
|
| Receptors, Somatostatin | 2 | 2020 | 94 | 0.090 |
Why?
|
| Glioma | 1 | 2022 | 1986 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 2403 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 12040 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2021 | 13445 | 0.090 |
Why?
|
| Sulfonylurea Receptors | 4 | 2002 | 23 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 5165 | 0.080 |
Why?
|
| Texas | 1 | 2020 | 6452 | 0.080 |
Why?
|
| Male | 11 | 2022 | 128484 | 0.080 |
Why?
|
| Lymphoma | 1 | 2016 | 1516 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2014 | 1044 | 0.070 |
Why?
|
| Radionuclide Imaging | 2 | 2021 | 654 | 0.070 |
Why?
|
| Tertiary Care Centers | 2 | 2021 | 418 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2674 | 0.070 |
Why?
|
| Mice | 5 | 2018 | 35477 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2022 | 33808 | 0.050 |
Why?
|
| United States | 1 | 2020 | 15891 | 0.050 |
Why?
|
| Carbazoles | 1 | 2002 | 88 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 238 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2002 | 381 | 0.050 |
Why?
|
| Glucose Intolerance | 1 | 2002 | 85 | 0.050 |
Why?
|
| Young Adult | 2 | 2017 | 22293 | 0.050 |
Why?
|
| Cryptorchidism | 1 | 2021 | 49 | 0.050 |
Why?
|
| Receptors, Peptide | 1 | 2021 | 87 | 0.050 |
Why?
|
| Radioisotopes | 1 | 2021 | 176 | 0.040 |
Why?
|
| Sulfonylurea Compounds | 1 | 2000 | 32 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2023 | 382 | 0.040 |
Why?
|
| Animals | 6 | 2018 | 61554 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2000 | 88 | 0.040 |
Why?
|
| Radiologists | 1 | 2022 | 179 | 0.040 |
Why?
|
| Intestinal Perforation | 1 | 2000 | 108 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 369 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 730 | 0.040 |
Why?
|
| Female | 8 | 2021 | 149120 | 0.040 |
Why?
|
| Eye | 1 | 2021 | 284 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2000 | 171 | 0.040 |
Why?
|
| Amino Acids | 1 | 2022 | 746 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 658 | 0.040 |
Why?
|
| Documentation | 1 | 2021 | 213 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2021 | 1023 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2023 | 1042 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2000 | 443 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 6191 | 0.040 |
Why?
|
| Colitis | 1 | 2021 | 340 | 0.040 |
Why?
|
| Reference Values | 2 | 2015 | 1129 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 483 | 0.040 |
Why?
|
| Hypoglycemia | 1 | 2000 | 220 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1107 | 0.040 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2000 | 189 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2021 | 524 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 4392 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2002 | 1255 | 0.040 |
Why?
|
| Tertiary Healthcare | 1 | 2015 | 46 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 1626 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2019 | 605 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2000 | 1516 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 4838 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 1692 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1994 | 136 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8709 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2002 | 1942 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1258 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 1692 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1994 | 631 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 3488 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2019 | 2440 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 4642 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 4994 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 1630 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 9039 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2002 | 511 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2002 | 1306 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 82174 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 15282 | 0.010 |
Why?
|
| Glucagon-Like Peptides | 1 | 2002 | 33 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2002 | 73 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2002 | 125 | 0.010 |
Why?
|
| Insulinoma | 1 | 2002 | 53 | 0.010 |
Why?
|
| Base Sequence | 2 | 2002 | 5417 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2002 | 213 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 256 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2002 | 6655 | 0.010 |
Why?
|
| Perfusion | 1 | 2002 | 281 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2002 | 412 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 1123 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 653 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 1801 | 0.010 |
Why?
|
| Pyrroles | 1 | 2002 | 588 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2002 | 1684 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 626 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 2249 | 0.010 |
Why?
|
| Indoles | 1 | 2002 | 1029 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 3110 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 3587 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 3472 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 1942 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 3204 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 5759 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 3533 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 3606 | 0.010 |
Why?
|
| Half-Life | 1 | 1994 | 268 | 0.010 |
Why?
|
| Rats | 1 | 2002 | 6404 | 0.010 |
Why?
|
| Cricetinae | 1 | 1994 | 762 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 5056 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 7645 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 4542 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 5326 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 2002 | 5263 | 0.000 |
Why?
|